HK Stock Market Move | GALAXIS TECH (02729) surged nearly 7% against the market trend, focusing on intelligent in-house logistics in the Siasun Robot & Automation sector. Revenue in September increased by over 60% compared to 25 years ago.
Cathay Land Technology (02729) rose nearly 7% against the market trend, and as of the time of writing, it increased by 4.4% to 31.32 Hong Kong dollars with a trading volume of 12.1688 million Hong Kong dollars.
GALAXIS TECH (02729) rose by nearly 7% against the market, rising by 4.4% as of the time of writing, to HK$31.32, with a trading volume of HK$121.688 million.
Public information shows that GALAXIS TECH focuses on the field of intelligent in-plant logistics with Siasun Robot&Automation, featuring three major product lines: multi-directional shuttle Siasun Robot&Automation, autonomous mobile Siasun Robot&Automation, and conveyor sorting Siasun Robot&Automation, deepening the intelligent upgrading of warehouse logistics in scenarios such as pharmaceuticals, e-commerce, and manufacturing. According to Frost & Sullivan data, based on revenue in 2024, GALAXIS TECH ranks among the top five comprehensive intelligent in-plant logistics Siasun Robot&Automation companies in China. In 2024, the company's VNA AMR shipment volume ranked first in China.
The prospectus shows that GALAXIS TECH achieved a revenue of 721 million yuan in 2024, a year-on-year increase of 30.8%; in the first nine months of 2025, it achieved a revenue of 552 million yuan, a year-on-year increase of 60.3%. As of the end of 2024, the company has implemented 1,530 projects, serving 779 customers, covering 28 segments including new energy, automotive, pharmaceuticals, e-commerce, and operating in 16 countries and regions globally.
Related Articles

ANALOGUE HLDGS(01977) will forfeit unclaimed 2019 second interim dividend.

The new weight loss drug from LLY.US has been approved by the FDA, marking the entry of the weight loss drug market into the "oral administration era".

Alibaba (09988) releases the strongest domestic programming model Qwen3.6-Plus
ANALOGUE HLDGS(01977) will forfeit unclaimed 2019 second interim dividend.

The new weight loss drug from LLY.US has been approved by the FDA, marking the entry of the weight loss drug market into the "oral administration era".

Alibaba (09988) releases the strongest domestic programming model Qwen3.6-Plus






